Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW,North American Actuarial Journal

当前位置： X-MOL 学术 › North American Actuarial Journal › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW
North American Actuarial Journal Pub Date : 2022-09-09 , DOI: 10.1080/10920277.2022.2102041
Sabyasachi Ghosh ₁ , Ian Smith ₂ , James Davidson ₂ , Tao Fan ₁ , Ninfa Candela ₁ , Cynthia Tsang ₁ , Troy Koch ₁ , Jason Fehr ₂

Affiliation

Payer-addressable burden (PAB) reflects how real-world disease-associated costs impact the per member per month (PMPM) budget of a health plan, and can help to delineate drivers of PMPM costs and i...

中文翻译：